2008 Alzheimer's disease facts and figures
- PMID: 18631956
- DOI: 10.1016/j.jalz.2008.02.005
2008 Alzheimer's disease facts and figures
Abstract
Alzheimer's disease is the seventh leading cause of all deaths in the United States and the fifth leading cause of death in Americans older than the age of 65 years. More than 5 million Americans are estimated to have Alzheimer's disease. Every 71 seconds someone in America develops Alzheimer's disease; by 2050 it is expected to occur every 33 seconds. During the coming decades, baby boomers are projected to add 10 million people to these numbers. By 2050, the incidence of Alzheimer's disease is expected to approach nearly a million people per year, with a total estimated prevalence of 11 to 16 million persons. Significant cost implications related to Alzheimer's disease and other dementias include an estimated $148 billion annually in direct (Medicare/Medicaid) and indirect (eg, caregiver lost wages and out-of-pocket expenses, decreased business productivity) costs. Not included in these figures are the estimated 10 million caregivers who annually provide $89 billion in unpaid services to individuals with Alzheimer's disease. This report provides information to increase understanding of the public health impact of Alzheimer's disease, including incidence and prevalence, mortality, lifetime risks, costs, and impact on family caregivers.
Similar articles
-
2009 Alzheimer's disease facts and figures.Alzheimers Dement. 2009 May;5(3):234-70. doi: 10.1016/j.jalz.2009.03.001. Alzheimers Dement. 2009. PMID: 19426951
-
2010 Alzheimer's disease facts and figures.Alzheimers Dement. 2010 Mar;6(2):158-94. doi: 10.1016/j.jalz.2010.01.009. Alzheimers Dement. 2010. PMID: 20298981
-
2012 Alzheimer's disease facts and figures.Alzheimers Dement. 2012;8(2):131-68. doi: 10.1016/j.jalz.2012.02.001. Alzheimers Dement. 2012. PMID: 22404854
-
Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective.Am J Manag Care. 2001 Aug;7(8):809-18. Am J Manag Care. 2001. PMID: 11519239 Review.
-
Diagnosis and treatment of Alzheimer's disease.J Clin Psychiatry. 2003;64 Suppl 9:3-6. J Clin Psychiatry. 2003. PMID: 12934967 Review.
Cited by
-
Increased Risk of Dementia in Patients with Tension-Type Headache: A Nationwide Retrospective Population-Based Cohort Study.PLoS One. 2016 Jun 7;11(6):e0156097. doi: 10.1371/journal.pone.0156097. eCollection 2016. PLoS One. 2016. PMID: 27272332 Free PMC article. Clinical Trial.
-
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.Alzheimers Dement. 2009 Mar;5(2):85-92. doi: 10.1016/j.jalz.2009.01.021. Alzheimers Dement. 2009. PMID: 19328434 Free PMC article.
-
Pathways of Prevention: A Scoping Review of Dietary and Exercise Interventions for Neurocognition.Brain Plast. 2019 Dec 26;5(1):3-38. doi: 10.3233/BPL-190083. Brain Plast. 2019. PMID: 31970058 Free PMC article.
-
Novel age-dependent learning deficits in a mouse model of Alzheimer's disease: implications for translational research.Neurobiol Aging. 2011 Jul;32(7):1273-85. doi: 10.1016/j.neurobiolaging.2009.08.003. Epub 2009 Aug 31. Neurobiol Aging. 2011. PMID: 19720431 Free PMC article.
-
Screening the methanol extracts of some Iranian plants for acetylcholinesterase inhibitory activity.Res Pharm Sci. 2009 Jul;4(2):105-12. Res Pharm Sci. 2009. PMID: 21589805 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical